Yaser Al Malik

Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study

Mohammed Aljumah, R. Bunyan, Hessa Al Otaibi et al. · BMC Neurology · 2020 · 125 citations · Full text

Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223

Brian Steingo, Yaser Al Malik, Ann Bass et al. · Journal of Neurology · 2020 · 52 citations · Full text

Familial aggregation of multiple sclerosis: Results from the national registry of the disease in Saudi Arabia

Mohammed Aljumah, Hessa Al Otaibi, Ghada Al Towaijri et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2020 · 18 citations · Full text

Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry

Eslam Shosha, Abdulla Al‐Asmi, Eman Nasim et al. · Multiple Sclerosis and Related Disorders · 2019 · 15 citations

Arabian Gulf, Patient Registry, Ophthalmology +5

Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report

Muhannad A Alnahdi, Sultan Ibrahim Aljarba, Yaser Al Malik · Multiple Sclerosis and Related Disorders · 2020 · 15 citations · Full text

Thrombosis, Alemtuzumab-induced Simultaneous Onset, Autoimmune Disease +12